Hites Maya; Massonnaud Clément R; Jamard Simon; Goehringer François; Danion François; Reignier Jean; de Castro Nathalie; Garot Denis; Lapique Eva Larranaga; Lacombe Karine; Tolsma Violaine; Faure Emmanuel; Malvy Denis; Staub Thérèse; Courjon Johan; Cazenave-Roblot France; Riise Anne Ma Dyrhol; Leturnier Paul; Martin-Blondel Guillaume; Roger Claire; Akinosoglou Karolina; Moing Vincent Le; Piroth Lionel; Sellier Pierre; Lescure Xavier; Trøseid Marius; Clevenbergh Philippe; Dalgard Olav; Gallien Sébastien; Gousseff Marie; Hajdú Edit; Kollaborációs szervezet: DisCoVeRy study group; et al.:
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : a phase 3, randomized, double-blind, placebo-controlled trial.
JOURNAL OF INFECTION, 88 (3).
ISSN 0163-4453
(2024)